Stock market news

TMK

TMK plans to start supplying complexes for laser-hybrid welding of pipe butt seams next year, said Sergey Chikalov, General Director of TMK. Combination of factory welding of longitudinal seams and annular butt welding using laser technology makes it possible to guarantee the same joint properties.

Abrau-Durso

Board of Directors of Abrau-Durso decided to appoint Elena Zaritskaya as the company's CEO from November 1. Previously Elena Zaritskaya headed the investment activities of the group of companies and supervised M&A transactions. Former CEO Vladimir Maslovsky decided to leave the company at his own will.

Rosseti Centere

Rosseti Center's RAS net profit for 9 months of 2023 amounted to ₽6.41 billion, up 79.5% from ₽3.571 billion in the previous year. Revenue rose 13.4% to ₽87.758 billion against ₽77.404 billion a year earlier.

Rosseti Center and Volga Region

Rosseti Center and Volga Region's RAS net profit for 9 months of 2023 amounted to ₽11.888 billion, up 44.2% from ₽8.244 billion in the previous year. Revenue rose 14.9% to ₽92.722 billion against ₽80.697 billion a year earlier.

Nauka-Svyaz

Nauka-Svyaz's RAS net profit for 9 months of 2023 amounted to ₽732,000, up 11 times from ₽66,000 in the previous year. Revenue increased 7.8% to ₽48,306 million vs. ₽44,793 million a year earlier.

RUSAL

Rusal's RAS net profit for 9 months of 2023 amounted to ₽2.466 billion, down 29 times from ₽71.524 billion in the previous year.

TNS Energy Kuban

TNS Energy Kuban's RAS net profit for 9 months of 2023 amounted to ₽5.831 billion, up 17.4 times from ₽0.335 billion in the previous year. Revenue rose 15.6% to ₽60.763 billion against ₽52.542 billion a year earlier.

Perm Energy Supply Company

Perm Power Supply Company's RAS net profit for 9 months of 2023 amounted to ₽942.75 million, up 36.9% from ₽688.87 million in the previous year. Revenue rose 9.1% to ₽32.782 billion against ₽30.041 billion a year earlier.

Amgen

Amgen's GAAP net income for 9 months of 2023 was $5.95 billion, up 20.4% from $4.94 billion in the prior year. Revenue increased by 2.6% to $19.994 bln vs. $19.484 bln a year earlier.

Pfizer

Pfizer's GAAP net income for 9 months of 2023 amounted to $5.518 billion, down 4.8 times from $26.404 billion in the previous year. Revenue declined 41.8% to $44.247 billion from $76.04 billion a year earlier.